Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: endobronchial obstruction major surgical or invasive procedure: flexible bronchoscopy rigid bronchoscopy with y stent placement history of present illness: ms. has a history of non-small cell lung/breast cancer with central airway obstruction. transferred here from for airway evaluation and possible stent placement. past medical history: non-small cell lung cancer breast cancer now on chemotherapy social history: patient does not smoke or use etoh family history: noncontributory physical exam: vital signs stable, intubated general: intubated heart: rrr, -mrg lungs: loud upper airway sounds abd: soft, nontender, nondistended. +bs pertinent results: 03:13pm glucose-151* urea n-13 creat-0.5 sodium-136 potassium-3.6 chloride-99 total co2-26 anion gap-15 03:13pm estgfr-using this 03:13pm calcium-8.0* phosphate-3.1 magnesium-2.0 03:13pm wbc-12.0*# rbc-3.24* hgb-11.8* hct-33.6* mcv-104* mch-36.3* mchc-35.0 rdw-22.4* 03:13pm plt smr-very low plt count-23*# 03:13pm pt-11.6 ptt-19.8* inr(pt)-1.0 cxr - cardiac size is top normal. there is widening of the mediastinum, greater on the right side in the right lower paratracheal region and right superior perihilar region. this could be due to lymphadenopathy and/or post-radiation changes if the patient has had radiation. mass-like opacity in the left suprahilar region measures 49 x 56 mm. ill-defined faint opacity in the right upper lobe due to interstitial abnormality could be secondary to radiation. other smaller lung nodules are seen in the lower lobes bilaterally. left lower lobe retrocardiac opacity likely represent atelectasis. there is no pneumothorax or pleural effusion. brief hospital course: patient was admitted to the icu for her upper airway obstruction. she was transferred intubated from for stent removal. she underwent flexible bronchoscopy for airway evaluation on . this was followed by rigid bronchoscopy with y-stent removal for her documented upper airway obstruction. she did well after the procedure and was extubated without difficulty. she was transferred back to for further evaluation and treatment. medications on admission: advair 250/50 once a day, ativan 2mg hs, decadron 10mg once a day, lexapro, insulin, mucinex discharge medications: 1. codeine phosphate 15 mg/ml syringe sig: one (1) injection q4-6h (every 4 to 6 hours) as needed for cough. 2. albuterol sulfate 0.083 % (0.83 mg/ml) solution sig: one (1) inhalation q4h (every 4 hours) as needed. 3. ipratropium bromide 0.02 % solution sig: one (1) inhalation q4h (every 4 hours) as needed. 4. dexamethasone 4 mg tablet sig: 2.5 tablets po daily (daily). 5. lorazepam 1 mg tablet sig: two (2) tablet po hs (at bedtime). 6. escitalopram 10 mg tablet sig: one (1) tablet po daily (daily). 7. guaifenesin 600 mg tablet sustained release sig: two (2) tablet sustained release po bid (2 times a day). 8. dextromethorphan poly complex 30 mg/5 ml suspension, sust.release 12 hr sig: ten (10) ml po q12h (every 12 hours) as needed. 9. insulin regular human 100 unit/ml solution sig: one (1) injection asdir (as directed). 10. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 11. famotidine 20 mg tablet sig: one (1) tablet po bid (2 times a day). 12. trimethoprim-sulfamethoxazole 160-800 mg tablet sig: one (1) tablet po bid (2 times a day). 13. scopolamine base 1.5 mg patch 72 hr sig: one (1) patch 72 hr transdermal once (once) for 1 doses. 14. lidocaine hcl 1 % (10 mg/ml) solution sig: one (1) ml injection q1-2h () as needed for cough. 15. potassium chloride 10 meq capsule, sustained release sig: four (4) capsule, sustained release po once (once) for 1 doses. 16. lorazepam 1 mg tablet sig: one (1) tablet po once (once) for 1 doses. 17. levofloxacin in d5w 750 mg/150 ml piggyback sig: one (1) intravenous daily (daily). 18. ondansetron hcl (pf) 4 mg/2 ml solution sig: one (1) injection q8h (every 8 hours) as needed. 19. heparin lock flush (porcine) 100 unit/ml syringe sig: two (2) ml intravenous daily (daily) as needed. discharge disposition: extended care discharge diagnosis: endobronchial obstruction discharge condition: still requiring further hospitalization discharge instructions: resume previous hospital care. please call dr. with any questions about your stent at . followup instructions: please call dr. office for a follow-up appointment in 2 weeks at . md procedure: other intubation of respiratory tract closed [endoscopic] biopsy of bronchus transfusion of platelets diagnoses: thrombocytopenia, unspecified malignant neoplasm of liver, secondary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified secondary malignant neoplasm of brain and spinal cord long-term (current) use of insulin secondary malignant neoplasm of bone and bone marrow malignant neoplasm of main bronchus shortness of breath secondary malignant neoplasm of kidney malignant neoplasm of other specified sites of female breast 

Answer: The patient is high likely exposed to